Vardenafil (Levitra/Staxyn) Side-Effect Reports From Real Users

At a glance
- Most common user-reported side effect / headache (trial rate: 15-21%)
- Second most common complaint / facial flushing (trial rate: 11-13%)
- Nasal congestion / reported by roughly 9-10% in trials
- Dyspepsia (upset stomach) / 4-6% in key trials
- Back pain / reported at 2-4% across dose ranges
- Vision changes (blue tinge) / rare, more associated with sildenafil but occasionally reported
- Priapism / extremely rare but cited repeatedly in forums due to fear factor
- Drugs.com average user rating / approximately 8.2 out of 10 for ED
- Onset of side effects / typically within 30-60 minutes of dosing
- Duration of side effects / most resolve within 2-4 hours
What Clinical Trials Established About Vardenafil Side Effects
The key phase III trial by Porst et al. (N=580) established the side-effect profile that regulatory agencies used to approve vardenafil [1]. Headache topped the list at 15% for 10 mg and 21% for 20 mg, compared to 5% for placebo. Flushing followed at 11-13%, nasal congestion at 9-10%, and dyspepsia at 4-6%.
These numbers set the baseline. But clinical trials recruit narrowly. The Porst trial excluded men with uncontrolled hypertension, men on nitrates, and men with significant hepatic impairment. Real-world users include people with comorbidities, polypharmacy, and variable alcohol intake that trials deliberately screen out. That gap between trial populations and real populations is exactly why user-reported data matters, even with its obvious limitations.
A separate trial in men with diabetes-related ED confirmed vardenafil's efficacy and showed a similar side-effect distribution in a metabolically complex population [2]. The rate of discontinuation due to adverse events remained low at approximately 3-5% across studies.
What Reddit Users Say About Side Effects
Reddit threads across r/Trt, r/erectile_dysfunction, and general men's health subreddits provide unfiltered accounts of vardenafil experiences. The most frequently mentioned complaint is headache, which aligns precisely with trial data. Users describe it as a "pressure headache" that starts 30-45 minutes after dosing and fades over 2-3 hours.
Flushing is the second most discussed side effect. One recurring theme in Reddit posts: users who switched from sildenafil to vardenafil report less facial flushing with vardenafil, though this is anecdotal and not supported by head-to-head trial comparisons on flushing severity.
Nasal congestion gets mentioned frequently but tends to bother users less than headache. Several posters describe it as tolerable. A less common but notable complaint in Reddit threads is mild back pain or myalgia, typically appearing the day after use and lasting 12-24 hours.
Selection bias is significant in these posts. People who take vardenafil without problems rarely post about it. The posts that gain visibility tend to describe either unusually positive results or concerning side effects. This skews the perceived side-effect rate upward compared to controlled data.
What Drugs.com Reviews Reveal
Drugs.com aggregates patient-submitted reviews with numerical ratings. Vardenafil (listed under both Levitra and generic vardenafil) carries an average rating of approximately 8.2 out of 10 for erectile dysfunction, based on several hundred reviews. This places it among the higher-rated PDE5 inhibitors on the platform.
The most common negative comments mirror the trial data: headache, flushing, and congestion. A subset of reviewers mention visual disturbances, specifically a slight blue-green color tint. This effect is more commonly associated with sildenafil due to its higher affinity for PDE6 in the retina [3], but some vardenafil users report mild versions.
Reviewers who rate vardenafil highly tend to mention two things: reliable onset within 30-60 minutes and fewer side effects compared to sildenafil. Reviewers who rate it lower often cite headache severity or cost as primary concerns. Discontinuation in patient reviews appears driven more by cost and insurance coverage than by intolerable side effects.
A pattern worth noting: several reviewers describe adjusting their dose downward from 20 mg to 10 mg to manage headache, and report that this solved the problem without sacrificing efficacy. The FDA prescribing information recommends starting at 10 mg for this reason [4].
How Vardenafil Side Effects Compare to Other PDE5 Inhibitors
Users frequently compare vardenafil against sildenafil and tadalafil. These comparisons are subjective, but they recur with enough consistency to identify patterns.
Versus sildenafil: users often describe vardenafil as producing less flushing and fewer visual side effects. A meta-analysis of PDE5 inhibitor trials found that all three agents produce headache and flushing at broadly similar rates, though individual response varies considerably [5]. The pharmacological explanation is that vardenafil has intermediate PDE6 selectivity between sildenafil (higher cross-reactivity) and tadalafil (lower cross-reactivity), which may account for the anecdotal vision-effect differences.
Versus tadalafil: the key user-reported distinction is duration. Tadalafil's 17.5-hour half-life means side effects, when they occur, last longer. Vardenafil's 4-5 hour half-life means side effects typically resolve the same day. Some users specifically prefer vardenafil for this reason. Others prefer tadalafil's longer window despite potentially more prolonged side effects.
Back pain and myalgia appear more frequently in tadalafil reviews than vardenafil reviews, both in user forums and in clinical data. The Endocrine Society's clinical practice guidelines on male hypogonadism note PDE5 inhibitors as first-line therapy for ED but do not rank them against each other for side-effect tolerability [6].
Serious Side Effects: What the Data Actually Shows
Online forums amplify rare events. Priapism (an erection lasting more than 4 hours) is discussed in virtually every PDE5 inhibitor thread, but its actual incidence is estimated at fewer than 1 in 10,000 uses across the PDE5 inhibitor class [7]. No large vardenafil trial reported priapism as a statistically significant event.
Sudden hearing loss has been reported with all PDE5 inhibitors as a post-marketing event. The FDA added a warning to all PDE5 inhibitor labels in 2007 [4]. The absolute risk remains extremely low, and a causal mechanism has not been definitively established. User forums occasionally reference this warning, but actual reports of hearing loss attributed to vardenafil are exceedingly rare in patient review databases.
Cardiovascular events receive attention because many ED patients have underlying cardiovascular risk factors. The American Heart Association has stated that PDE5 inhibitors do not increase cardiovascular risk in appropriately screened patients [8]. The absolute contraindication remains concurrent nitrate use, which can cause dangerous hypotension.
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a principal investigator on multiple ED trials, has noted: "PDE5 inhibitors as a class have an established safety profile spanning over two decades of clinical use. The side effects are predictable, dose-dependent, and rarely treatment-limiting."
The Staxyn (ODT) Formulation and Side-Effect Differences
Staxyn is vardenafil in an orally disintegrating tablet (ODT) formulation. It dissolves on the tongue without water. The bioavailability differs from standard tablets, which is why Staxyn is available only as a 10 mg ODT, not interchangeable milligram-for-milligram with Levitra tablets.
User reviews of Staxyn specifically mention a strong peppermint taste and faster perceived onset. The side-effect profile in clinical data is essentially the same as the standard tablet [4]. Some users report that the ODT causes less dyspepsia, possibly because it bypasses direct gastric exposure, though this has not been confirmed in comparative trials.
Staxyn tends to receive fewer online reviews simply because it costs more and has lower market penetration than generic vardenafil tablets. The reviews that do exist skew positive, likely reflecting a population that specifically sought out the ODT formulation and was willing to pay premium pricing.
Dose-Dependent Side Effects: The 5 mg, 10 mg, and 20 mg Picture
Side effects with vardenafil follow a clear dose-response curve. The Porst et al. trial documented headache at 10% (5 mg), 15% (10 mg), and 21% (20 mg) versus 5% for placebo [1]. Flushing showed a similar gradient. This pattern is consistent across all PDE5 inhibitors and is pharmacologically expected.
User forums reflect this. Posters who describe severe headaches are often taking 20 mg. The most common advice from experienced users in Reddit threads is to start at 10 mg. This aligns with FDA labeling, which recommends 10 mg as the starting dose, with adjustments to 5 mg or 20 mg based on efficacy and tolerability [4].
Older adults and men with hepatic impairment are advised to start at 5 mg. The American Urological Association guidelines on ED management recommend dose titration as a standard approach for all PDE5 inhibitors [9].
A practical point that appears in user discussions: taking vardenafil on a full stomach, particularly after a high-fat meal, can delay absorption by up to 60 minutes. This does not change the overall side-effect incidence, but it shifts the timing, which some users interpret as "it didn't work" followed by delayed onset of both effect and side effects.
Drug Interactions That Amplify Side Effects
The most dangerous interaction is with nitrates. This is absolute. Vardenafil with nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate can produce life-threatening hypotension [4].
Alpha-blockers (tamsulosin, doxazosin, terazosin) used for benign prostatic hyperplasia can potentiate vardenafil's blood-pressure-lowering effect. The FDA label recommends stable alpha-blocker therapy before adding vardenafil, and starting vardenafil at 5 mg in these patients [4].
CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) increase vardenafil plasma levels significantly. A dose reduction to 5 mg maximum is recommended when co-administered with potent CYP3A4 inhibitors, and some combinations require even lower doses [4].
Grapefruit juice, a mild CYP3A4 inhibitor, is mentioned in user forums as something to avoid. The clinical significance is modest at normal consumption levels, but heavy grapefruit intake could increase vardenafil exposure enough to worsen headache and flushing.
User forums occasionally reference combining vardenafil with other ED treatments. Combining PDE5 inhibitors with each other, or with alprostadil injections, increases the risk of priapism and hypotension. This practice falls outside clinical guidelines and should only occur under direct physician supervision.
How to Manage Common Vardenafil Side Effects
For headache, the most effective user-reported strategy is pretreatment with ibuprofen 200-400 mg taken 30 minutes before vardenafil. A small study found that prophylactic NSAIDs reduced PDE5 inhibitor-associated headache without affecting efficacy [10]. Acetaminophen is an alternative for those who cannot take NSAIDs.
For flushing, the evidence for prevention is limited. Avoiding alcohol reduces flushing intensity, as alcohol independently causes vasodilation. Some users report that staying well-hydrated helps, though no controlled data supports this specifically.
For nasal congestion, pseudoephedrine or a saline nasal spray taken beforehand may help. The congestion is caused by vasodilation in nasal mucosa and typically resolves as the drug clears.
The Endocrine Society recommends that if side effects are intolerable at the effective dose, patients should try a different PDE5 inhibitor before considering second-line therapies like intracavernosal injection or vacuum devices [6]. Individual responses to PDE5 inhibitors vary enough that switching agents is a reasonable first step.
As the AUA's 2018 guideline panel stated: "Clinicians should inform patients that a lack of response or intolerable side effects with one PDE5 inhibitor does not predict failure with another" [9].
Understanding Forum Bias in Side-Effect Reports
Every online patient forum carries inherent bias. People in distress post more than people who are satisfied. This is called negative response bias, and it inflates the perceived rate of side effects in any user-review database.
Drugs.com reviews partially mitigate this by including numerical ratings, which trend positive for vardenafil (average ~8.2/10). Reddit offers raw, unstructured accounts with no rating system, making it harder to gauge overall satisfaction. PatientsLikeMe provides more structured symptom tracking but has a smaller vardenafil user base.
The sample sizes matter. A Reddit thread with 15 comments about headaches does not represent 15 out of 15 users getting headaches. It represents 15 people out of an unknown denominator who felt compelled to describe their experience. The clinical trial denominator of 580 patients randomized in the Porst study [1] provides a far more reliable rate estimate.
Use forum data for qualitative insight: what the side effects feel like, how long they last, what helps. Use clinical trial data for quantitative estimates: how often side effects occur and at what doses. Combining both gives a more complete picture than either source alone.
Patients experiencing any persistent or concerning side effects from vardenafil should contact their prescribing physician. Standard monitoring includes blood pressure assessment at follow-up visits, and men taking vardenafil should report any sudden changes in vision or hearing immediately [4].
Frequently asked questions
›Does vardenafil (Levitra/Staxyn) actually work?
›What do people say about vardenafil (Levitra/Staxyn)?
›What is the most common side effect of vardenafil?
›Is vardenafil safer than sildenafil?
›Can I take vardenafil with blood pressure medication?
›How long do vardenafil side effects last?
›Does vardenafil cause vision changes?
›Is the Staxyn ODT formulation better tolerated?
›Can I drink alcohol with vardenafil?
›What should I do if I get a severe headache from vardenafil?
›Does vardenafil cause heart problems?
›How does vardenafil compare to tadalafil for side effects?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199.
- Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care. 2003;26(3):777-783.
- Laties A, Zrenner E. Viagra (sildenafil citrate) and ophthalmology. Prog Retin Eye Res. 2002;21(5):485-506.
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information. FDA label, revised 2014.
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912.
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
- Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1):1318-1324.
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072.
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641.
- Gladwell TD. Use of paracetamol (acetaminophen) for PDE5 inhibitor headaches. Int J Impot Res. 2004;16(suppl 1):S24.